Amryt Pharma (AMYT)
NASDAQ: AMYT
· Real-Time Price · USD
14.70
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM
Amryt Pharma Revenue
Amryt Pharma reported an annual revenue of $222.54M, reflecting a 21.87% growth. For the quarter ending September 30, 2022, Amryt Pharma generated $61.13M in revenue.
Revenue (ttm)
222.54M
Revenue Growth
21.87%
Price / Sales Ratio
2.29
Revenue / Employee
770.04K
Employees
289
Market Cap
0
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2021 | 222.54M | +21.87% |
| Dec 31, 2020 | 182.61M | +214.17% |
| Dec 31, 2019 | 58.12M | +251.54% |
| Dec 31, 2018 | 16.53M | +7.85% |
| Dec 31, 2017 | 15.33M | +978.82% |
| Dec 31, 2016 | 1.42M | +Infinity% |
| Mar 31, 2015 | 0 | n/a |
| Mar 31, 2014 | 0 | n/a |
| Mar 31, 2013 | 0 | n/a |
| Mar 31, 2012 | 0 | n/a |
| Mar 31, 2011 | 0 | n/a |
| Mar 31, 2010 | 0 | n/a |
| Mar 31, 2009 | 0 | n/a |
| Mar 31, 2008 | 0 | n/a |
| Dec 31, 2007 | 0 | n/a |